Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 16Unknown 8Active not recruiting 7Withdrawn 4Terminated 4Recruiting 2Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 4Plasma cell 1Myeloid 1Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 140Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Hematologic Neoplasms 69Myelodysplastic Syndromes 55Lymphoma 47Lymphoma, Non-Hodgkin 45Lymphoma, B-Cell, Marginal Zone 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34Lymphoma, Mantle-Cell 33Lymphoma, Follicular 33Burkitt Lymphoma 32Recurrence 28Lymphoma, Large B-Cell, Diffuse 28Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Hodgkin Disease 23Neoplasms 22Leukemia, Myelomonocytic, Chronic 22Multiple Myeloma 21Myeloproliferative Disorders 20Waldenstrom Macroglobulinemia 19Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic-Phase 17Congenital Abnormalities 16Primary Myelofibrosis 15Leukemia, Myeloid, Accelerated Phase 14Leukemia, Biphenotypic, Acute 14Mycosis Fungoides 13Lymphoma, T-Cell, Cutaneous 13

Interventions

ogalvibart 1crexavibart 1cilgavimab and tixagevimab drug combination 1Hydroxychloroquine 1Blood Specimen Collection 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × COVID-19 × Other hematologic neoplasm × Clear all
NCT04953312 2026-03-12

CALPRO

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT05465876 2024-04-04

PACE-CLL

Sunnybrook Health Sciences Centre

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05393999 2023-04-24

SABRE

Imperial College Healthcare NHS Trust

Phase 2 Withdrawn
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡